The discovery of orexins adds to a rapidly evolving picture of how food intake and body fat are regulated.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Fasting enhances extinction retention and prevents the return of fear in humans
Translational Psychiatry Open Access 09 October 2018
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Sakurai, T. et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G-protein-coupled receptors that regulate feeding behavior. Cell 92, 573–585 (1998).
Schwartz, M. & Seeley, R. Neuroendocrine responses to starvation and weight loss. New Engl. J. Med. 336, 1802–1811 (1997).
Stephens, T.W. et al. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 377, 530–532 (1995).
Schwartz, M.W. et al. Leptin increases proopiome-lanocortin (POMC) mRNA expression in the rostral arcuate nucleus. Diabetes 46, 2119–2123 (1997).
Cone, R. et al. The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation. Recent Progress In Hormone Research 51, 287–318 (1996).
Huszar, D. et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88, 131–141 (1997).
Ollmann, M. et al. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 278, 135–138 (1997).
Seeley, R. et al. Evidence that the hypothalamic melanocortin system mediates leptin's effects on food intake and body weight. Nature 390, 349 (1997).
Stanley, B.G., Kyrkouli, S.E., Lampert, S. & Leibowitz, S.F. Neuropeptide Y chronically injected into the hypothalamus: A powerful neurochemical inducer of hyperphagia and obesity. Peptides 7, 1189–1192 (1986).
Rossi, M. et al. Melanin-concentrating hormone acutely stimulates feeding, but chronic administration has no effect on body weight. Endocrinology 138, 351–155 (1997).
Smith, B., York, D. & Bray, G. Chronic cerebroventricular galanin does not induce sustained hyperphagia or obesity. Peptides 15, 1267–1272 (1994).
Schaffhauser, A.O. et al. Inhibition of food intake by neuropeptide Y Y5 receptor antisense oligodeoxynu-cleotides. Diabetes 46, 1792–1798 (1997).
Erickson, J.C., Clegg, K.E. & Palmiter, R.D. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 381, 415–418 (1996).
Connolly, H. et al. Valvular heart disease associated with fenfluramine-phentermine. New Engl. J. Med. 337, 581–588 (1997).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schwartz, M. Orexins and appetite: The big picture of energy homeostasis gets a little bigger. Nat Med 4, 385–386 (1998). https://doi.org/10.1038/nm0498-385
Issue Date:
DOI: https://doi.org/10.1038/nm0498-385
This article is cited by
-
Fasting enhances extinction retention and prevents the return of fear in humans
Translational Psychiatry (2018)
-
Hypocretins or hyporexins?
Nature Medicine (1998)